Log In
Print
BCIQ
Print
Print this Print this
 

Campath-1H, alemtuzumab (Lemtrada, MabCampath, Campath)

Also known as: MabCampath-1H alemtuzumab (LDP-03)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHumanized mAb against CD52
Molecular Target CD52
Mechanism of ActionBinds CD52; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today